Long-term inhaled corticosteroids in preschool children at high risk for asthma.

BACKGROUND It is unknown whether inhaled corticosteroids can modify the subsequent development of asthma in preschool children at high risk for asthma. METHODS We randomly assigned 285 participants two or three years of age with a positive asthma predictive index to treatment with fluticasone propionate (at a dose of 88 mug twice daily) or masked placebo for two years, followed by a one-year period without study medication. The primary outcome was the proportion of episode-free days during the observation year. RESULTS During the observation year, no significant differences were seen between the two groups in the proportion of episode-free days, the number of exacerbations, or lung function. During the treatment period, as compared with placebo use, use of the inhaled corticosteroid was associated with a greater proportion of episode-free days (P=0.006) and a lower rate of exacerbations (P<0.001) and of supplementary use of controller medication (P<0.001). In the inhaled-corticosteroid group, as compared with the placebo group, the mean increase in height was 1.1 cm less at 24 months (P<0.001), but by the end of the trial, the height increase was 0.7 cm less (P=0.008). During treatment, the inhaled corticosteroid reduced symptoms and exacerbations but slowed growth, albeit temporarily and not progressively. CONCLUSIONS In preschool children at high risk for asthma, two years of inhaled-corticosteroid therapy did not change the development of asthma symptoms or lung function during a third, treatment-free year. These findings do not provide support for a subsequent disease-modifying effect of inhaled corticosteroids after the treatment is discontinued. (ClinicalTrials.gov number, NCT00272441.).

[1]  B. Chipps Intermittent Inhaled Corticosteroids in Infants With Episodic Wheezing , 2007, Pediatrics.

[2]  H. Bisgaard,et al.  Understanding mild persistent asthma in children: the next frontier. , 2005, The Journal of allergy and clinical immunology.

[3]  C. Sorkness,et al.  Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. , 2004, The Journal of allergy and clinical immunology.

[4]  G. O'Connor,et al.  Results of a home-based environmental intervention among urban children with asthma. , 2004, The New England journal of medicine.

[5]  F. Leickly FLUTICASONE PROPIONATE IN ASTHMA: A LONG-TERM, DOSE-COMPARISON STUDY , 2004, Pediatrics.

[6]  Vernon M Chinchilli,et al.  The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. , 2004, Controlled clinical trials.

[7]  I. Bergadá,et al.  Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing , 2004, Pediatric pulmonology.

[8]  H. Bisgaard,et al.  Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. , 2004, Pediatrics.

[9]  M. Klinnert,et al.  Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. , 2003, The Journal of allergy and clinical immunology.

[10]  C. Pao,et al.  Randomized controlled trial of fluticasone in preschool children with intermittent wheeze. , 2002, American journal of respiratory and critical care medicine.

[11]  M. Goldman,et al.  Within‐ and between‐day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics , 2002, Pediatric pulmonology.

[12]  H. Bisgaard,et al.  Response of preschool children with asthma symptoms to fluticasone propionate. , 2001, The Journal of allergy and clinical immunology.

[13]  Y. Coyle,et al.  The use of parent report to assess the quality of care in primary care visits among children with asthma. , 2001, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[14]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[15]  S. Pedersen,et al.  Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. , 2000, The New England journal of medicine.

[16]  H. Bisgaard,et al.  The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. , 2000, American journal of respiratory and critical care medicine.

[17]  J. Castro‐Rodriguez,et al.  A clinical index to define risk of asthma in young children with recurrent wheezing. , 2000, American journal of respiratory and critical care medicine.

[18]  H. Bisgaard,et al.  The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. , 1999, American journal of respiratory and critical care medicine.

[19]  M. Brown,et al.  Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. , 1999, American journal of respiratory and critical care medicine.

[20]  F. Simons,et al.  A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. , 1997, The New England journal of medicine.

[21]  R. Roorda,et al.  One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. , 1997, American journal of respiratory and critical care medicine.

[22]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[23]  Ayne,et al.  ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .

[24]  S. Pedersen,et al.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. , 1994, Respiratory medicine.

[25]  M. Hughes,et al.  Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. , 1993, The American review of respiratory disease.

[26]  C E Reed,et al.  A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. , 1992, The American review of respiratory disease.

[27]  B. Burrows,et al.  The epidemiology of asthma. , 1985, Chest.